Amedisys Inc

Amedisys — Q3 2019 Earnings Presentation

21 slides from Amedisys's earnings presentation, Oct 29, 2019

  1. Slide 1: Third Quarter 2019 Earnings Call Supplemental Slides

    Amedisys Third Quarter 2019 Earnings Call Supplemental Slides October 30th, 2019 Exhibit 99.2

  2. Slide 2: Forward-looking statements

    This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau

  3. Slide 3: Our Key Areas of Focus

    Our Key Areas of Focus Strategic areas of focus for 2019 Home Health*: Total same store admissions +9%. Total same store volume +6%. Total same store Medicare admissions +5% Hospice: Admissions +4%, ADC +5% Personal Care: Billable hours / quarter +2% (including acquisitions) 1 Organic Growth Quality

  4. Slide 4: Highlights and Summary Financial Results (Adjusted): 3Q 2019

    Highlights and Summary Financial Results (Adjusted): 3Q 2019(1) Home Health total same store volume +6%, total same store admissions +9%. Hospice same store admissions +4%. Personal Care +2% billable hours. Amedisys Consolidated Revenue Growth: +19% EBITDA: $57M (+25%) EBITDA Margin: 12% (+70 bps) E

  5. Slide 5: Our revenue sources: 3Q19

    Our revenue sources: 3Q19 Medicare FFS: Paid episodically over a 60-day episode Private Episodic: MA and Commercial plans who pay us over a 60-day episode. Generally at rates ~90% – 100% of Medicare Per Visit: Managed care, Medicaid and private payors reimbursing us per visit provided Hospice Per Da

  6. Slide 6: Home Health and Hospice Segment (Adjusted) – 3Q 2019

    Home Health and Hospice Segment (Adjusted) – 3Q 2019(1) Medicare FFS growth +5% Revenue per Episode up +1.9% Recert rate down 180 bps Y/Y CPV up +$0.81 (+0.9%) EBITDA as a % percentage of revenue: +10 bps Home Health Highlights Same store average daily census (ADC) up 5% Net revenue per day +5.5% ~$

  7. Slide 7: General & Administrative Expenses – Adjusted

    General & Administrative Expenses – Adjusted (1,2) Notes: Year over year total G&A as a percentage of revenue increased 70 basis points Home Health segment G&A: 100 bps increase as % of revenue - 50 bps due to change in staffing model (reclass of Clinical Manager role from Cost of Revenue to G&A) an

  8. Slide 8: Industry Leading Quality Scores

    Industry Leading Quality Scores Note: Top Competitor Avg weighted by CCN count and includes LHC, Kindred, AFAM, EHC and BKD Metric APR 19 Release JUL 19 Release OCT 19 PREVIEW JAN 20 PREVIEW Quality of Patient Care 4.28 4.27 4.28 4.27 Entities at 4+ Stars 86% 85% 88% 86% Metric OCT 18 Release JAN 19

  9. Slide 9: Hospice Quality: Moving Towards Best-in-Class

    Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality

  10. Slide 10: Cost per Visit Components

    Components 3Q’18 2Q’19 3Q’19 YoY Variance Detail Initiatives Salaries $61.93 $61.69 $63.24 $1.31 YoY increase due to planned wage increases Staffing mix optimization, productivity and scheduling improvement initiatives in place to help overcome planned salary increases Contractors $3.35 $2.99 $2.83

  11. Slide 11: Driving Top Line Growth

    Driving Top Line Growth All three lines of business continue to grow. Hospice delivers another quarter of ADC growth and Home Health total same store volume continues to trend in the mid-single digits Home Health Total Volume Hospice ADC Personal Care Total Hours / Quarter *Includes impact of East T

  12. Slide 12: Debt and Liquidity Metrics

    Debt and Liquidity Metrics ~1.0x net leverage post Compassionate Care Hospice acquisition Net debt defined as total debt outstanding ($244.3M) less cash balance ($20.8M). Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($217.0M). Liquidity defined as the sum

  13. Slide 13: Cash Flow Statement Highlights

    Cash Flow Statement Highlights (1) Free cash flow defined as cash flow from operations less routine capital expenditures and required debt repayments.

  14. Slide 14: Income Statement Adjustments

    Income Statement Adjustments (1) The financial results for the three-month periods ended September 30, 2018, December 31, 2018, March 31, 2019, June 30, 2019 and September 30, 2019 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these non-GAA

  15. Slide 15: 2019 Guidance

    2019 Guidance

  16. Slide 16: Updating 2019 Guidance

    Updating 2019 Guidance Increasing 2019 EBITDA and EPS guidance ranges 2019 Updated Guidance (2Q) Revenue Adjusted EBITDA Adjusted Earnings per Share $205M - $210M $1.94B - $1.98B $3.98 – $4.09 2019 Original Guidance $213M - $216M $4.05– $4.12 $1.94B - $1.98B $220M - $223M $4.32– $4.39 $1.94B - $1.98

  17. Slide 17: 2019 Guidance Considerations

    2019 Guidance Considerations Amedisys Consolidated Tax rate ~26% Cash tax rate ~17% Diluted share count ~33.1 million shares Capital Expenditures ~$8-$10 million Salary increase ~2% - 3% Benefits increase ~12% (8% growth / headcount, 4% pricing / claims costs) Overall ~$6 million investment in busin

  18. Slide 18: Compassionate Care Hospice (CCH) EBITDA Improvement

    Compassionate Care Hospice (CCH) EBITDA Improvement HCHB disruption and investments in the business will impact EBITDA in 2019. EBITDA margin in 2020 and beyond will reflect legacy Amedisys hospice margin and growth trajectory Category Description ADC Disruption Negative impact on ADC as HCHB is ins

  19. Slide 19: Reimbursement Outlook

    Reimbursement Outlook Reimbursement Impact for Home Health and Hospice Home Health Hospice 2019 Market Basket Update 3.0% Productivity Adjustment (0.8)0 Estimated Industry Impact +2.2% Estimated AMED-Specific Impact +1.2% 2020* Market Basket Update 3.0% Productivity / Other Adjustment (0.4) Estimate

  20. Slide 20: EBITDA Seasonality: As Reported

    EBITDA Seasonality: As Reported Q1 Q2 Q3 Q4 Drivers of Seasonality Weather disruption Lower RPE (LUPA) Payroll tax reset Short Month (Feb.) Lower Hospice ADC & Higher Salary Cost per Day Highest Completed Episodes Stronger revenue per episode (RPE) Incremental holiday vs. 1H High PTO Lower Volumes H

  21. Slide 21: EBITDA Seasonality: Excluding Health Insurance and Workers Compensation

    EBITDA Seasonality: Excluding Health Insurance and Workers Compensation Q1 Q2 Q3 Q4 Drivers of Seasonality Weather disruption Lower RPE (LUPA) Payroll tax reset Short Month (Feb.) Lower Hospice ADC & Higher Salary Cost per Day Highest Completed Episodes Stronger revenue per episode (RPE) Incremental

Amedisys — Q3 2019 Earnings Presentation on 6ix